Elspar and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Elspar (asparaginase), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Methotrexate, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Weakness when taking Elspar. It is created by eHealthMe based on reports of 2,053 people who have side effects when taking Elspar from the FDA, and is updated regularly.

What is Elspar?

Elspar has active ingredients of asparaginase. eHealthMe is studying from 2,057 Elspar users. Check the latest studies of Elspar.

What is Weakness?

Weakness is found to be associated with 3,641 drugs and 6,605 conditions by eHealthMe. Check the latest studies of Weakness.

On Apr, 05, 2026

2,053 people reported to have side effects when taking Elspar.
Among them, 46 people (2.24%) have Weakness.

Among these 46 people:

How long have people been on Elspar when they have Weakness? *

What is the gender of people who have Weakness when taking Elspar? *

female: 37.78 %
male: 62.22 %

What is the age of people who have Weakness when taking Elspar? *

What are other drugs people take besides Elspar? *

What are other side effects people have besides Weakness? *

Fever: 8 people, 17.39%
Nausea (feeling of having an urge to vomit): 6 people, 13.04%
Haemoglobin Decreased: 6 people, 13.04%
Febrile Neutropenia (fever with reduced white blood cells): 6 people, 13.04%
Fatigue (feeling of tiredness): 6 people, 13.04%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 10.87%
Headache (pain in head): 5 people, 10.87%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 8.70%
Difficulty In Walking: 4 people, 8.70%
Areflexia (absence of a reflex): 4 people, 8.70%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 10 people, 21.74%
Aspergillosis (an infection caused by a fungus called aspergillus): 8 people, 17.39%
Sinusitis (inflammation of sinus): 3 people, 6.52%
Renal Tubular Disorder (disease of kidney tubules): 3 people, 6.52%
Pain: 3 people, 6.52%
Lip Dry: 3 people, 6.52%
Herpes Zoster: 3 people, 6.52%
Rashes (redness): 2 people, 4.35%
Neoplasm Malignant (cancer tumour): 2 people, 4.35%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 2 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Elspar and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elspar:

Elspar (2,057 reports)

Weakness treatments and more:

Weakness (586,875 reports)

Browse all side effects of Elspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,641 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,605 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on asparaginase (the active ingredients of Elspar) and Elspar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.